Portigon Ag:企業の戦略・SWOT・財務分析

◆英語タイトル:Portigon Ag - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3279
◆発行会社(調査会社):MarketLine
◆発行日:2019年11月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Portigon Ag – Strategy, SWOT and Corporate Finance Report
Summary

Portigon Ag – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Portigon AG (Portigon), a subsidiary of the State of North Rhine-Westphalia, is a specialist provider of services for portfolios of financial institutions. It offers services such as credit processing, trade-life-cycle management, risk rating services, regulatory reporting, and trade-life-cycle management, among others. The group provides end to end services to wind-down vehicles and banks with internal restructuring units, institutional investors, and commercial banks. The group has operational presence in Germany, the UK, the US, and Australia. It is headquartered in Dusseldorf, Germany.

Scope

- Detailed information on Portigon Ag required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Portigon Ag in the form of a SWOT analysis
- An in-depth view of the business model of Portigon Ag including a breakdown and examination of key business segments
- Intelligence on Portigon Ag’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Portigon Ag, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Portigon Ag and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Portigon Ag as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Portigon Ag’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Portigon AG: Company Overview
Portigon AG: Overview and Key Facts
Portigon AG: Overview
Portigon AG: Key Facts
Portigon AG: Key Employees
Portigon AG: Key Employee Biographies
Portigon AG: Major Products and Services
Portigon AG: Company History
Portigon AG: Management Statement
Portigon AG: Locations and Subsidiaries
Portigon AG: Key Competitors
Portigon AG: Company Analysis
Portigon AG: Business Description
Portigon AG: SWOT Analysis
Portigon AG: SWOT Overview
Portigon AG: Strengths
Portigon AG: Weaknesses
Portigon AG: Opportunities
Portigon AG: Threats
Portigon AG: Recent Developments
Portigon AG: News and Events Summary
Portigon AG: Corporate Governance
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Portigon AG: Key Facts
Table 2: Portigon AG: Key Employees
Table 3: Portigon AG: Company History
Table 4: Portigon AG: Locations and Subsidiaries
Table 5: Portigon AG: Key Competitors
Table 6: Portigon AG: News and Events Summary
Table 7: Portigon AG: Corporate Governance

★海外企業調査レポート[Portigon Ag:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cambrex Corp (CBM):製薬・医療:M&Aディール及び事業提携情報
    Summary Cambrex Corp (Cambrex) is a life science company that focuses on the development and commercialization of small molecule therapeutics. The company’s major products include active pharmaceutical ingredients (APIs), advanced intermediates and drug delivery products for branded and generic phar …
  • Presidio Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Presidio Pharmaceuticals Inc (Presidio) is a clinical-stage pharmaceutical company that discovers and develops small-molecule antiviral therapeutics. The company’s products include HCV NS5A, NS5B proteins, lead pan-genotypic HCV NS5A inhibitor, ravidasvir hydrochloride, protease inhibitor, f …
  • Huhtamaki Oyj:企業の戦略・SWOT・財務情報
    Huhtamaki Oyj - Strategy, SWOT and Corporate Finance Report Summary Huhtamaki Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Citrix Systems, Inc.:企業の戦略・SWOT・財務情報
    Citrix Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Citrix Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Hill International, Inc. (HIL):企業の財務・戦略的SWOT分析
    Hill International, Inc. (HIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • ConverGene LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary ConverGene LLC (ConverGene) is a small molecule discovery company that offers development of cancer drugs targeting the root regulatory mechanisms within cancer cells. The company develops small-molecule drugs that aim at bromodomains, a structural feature of proteins, which mediate epigenet …
  • Usha Martin Limited:企業の戦略・SWOT・財務情報
    Usha Martin Limited - Strategy, SWOT and Corporate Finance Report Summary Usha Martin Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Theralase Technologies Inc (TLT):企業の財務・戦略的SWOT分析
    Summary Theralase Technologies Inc (Theralase) is a clinical stage pharmaceutical company which specializes in design, development, and manufacturing of laser based technologies used in wide range of bio-destructive and bio-simulative clinical applications. The company is focused on the development …
  • Clean Harbors, Inc. (CLH)-石油・ガス分野:企業M&A・提携分析
    Summary Clean Harbors, Inc. (Clean Harbors) is a provider of environmental, industrial and energy services. The company offers waste disposal and recycling, emergency response, chemical packing, field services, production services, exploration services, directional boring, lodging services and insit …
  • The People’s Insurance Company (Group) of China Limited:企業の戦略・SWOT・財務情報
    The People's Insurance Company (Group) of China Limited - Strategy, SWOT and Corporate Finance Report Summary The People's Insurance Company (Group) of China Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • Abbott Diabetes Care Inc:製品パイプライン分析
    Summary Abbott Diabetes Care Inc (ADC), formerly TheraSense Inc, a subsidiary of Abbott Laboratories, is a medical device company that discovers, develops, manufactures, and markets pharmaceuticals and medical products for personal use and hospital use. The company’s products include glucose monitor …
  • Civica Group Limited:企業の戦略的SWOT分析
    Civica Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Vertical Computer Systems Inc (VCSY):企業の財務・戦略的SWOT分析
    Summary Vertical Computer Systems Inc (VCSY) is a technology company that develops and markets of application software, cloud-based and software services, internet core technologies, and intellectual property assets. The company provides products such as siteflash, responseflash, empath, snappnet, a …
  • Valeant Canada LP-製薬・医療分野:企業M&A・提携分析
    Summary Valeant Canada LP (Valeant Canada), a subsidiary of Valeant Pharmaceuticals International Inc, is a pharmaceutical company that manufactures, markets and distributes pharmaceutical products. The company offers its products in various therapeutic areas, including pain management, neurology, c …
  • Sernova Corp (SVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company develops Cell Pouch System, an implantable medical device, which offers a natural organ-like …
  • Spectris Plc (SXS):企業の財務・戦略的SWOT分析
    Spectris Plc (SXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • NEX Group plc. (IAP):企業の戦略的SWOT分析
    NEX Group plc. (IAP) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Chugai Pharmaceutical Co Ltd (4519)-製薬・医療分野:企業M&A・提携分析
    Summary Chugai Pharmaceutical Co Ltd (Chugai), a subsidiary of Hoffmann-La Roche Ltd, is a provider of biopharmaceuticals and therapeutic antibodies. The company offers products for the treatment of cancer; bone and joint diseases; renal diseases; immunology and infectious diseases and others. It al …
  • Anagin Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Anagin Inc (Anagin) formerly Anagin LLC, is a biotechnology company which develops novel targeted therapies for the treatment of neuropsychiatric diseases. The company is focused on the development of first-in-class small molecule modulators of neurotransmitter signaling complexes that reduc …
  • JM AB:企業の戦略・SWOT・財務情報
    JM AB - Strategy, SWOT and Corporate Finance Report Summary JM AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆